Shoemaker Daniel D

Chief Scientific Officer at FATE

Sold, on record
$6.7M
Dollars the filings state
Form 4 sales
11
Latest Mar 8, 2021
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

  • FATEFATE THERAPEUTICS INCChief Scientific Officer

Sales by reason

0
Routine
10
Plan not stated
0
No plan
1
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per year, every sale on record.

Sales chart range

Timeline

  1. Mar 8, 2021Unusual

    FATE

    Sold 25.5% of their holdings

    $2M25,000 shares at $81.73

    Filed Mar 9, 2021Form 4

  2. Jan 11, 2021Plan not stated

    FATE

    Sold 10.2% of their holdings

    $1.1M9,482 shares at $114.95

    Filed Jan 12, 2021Form 4

  3. Nov 16, 2020Plan not stated

    FATE

    Sold 21.2% of their holdings

    $1.3M25,000 shares at $51.83

    Filed Nov 16, 2020Form 4

  4. Sep 14, 2020Plan not stated

    FATE

    Sold 17.5% of their holdings

    $908k25,000 shares at $36.30

    Filed Sep 16, 2020Form 4

  5. Jan 8, 2020Plan not stated

    FATE

    Sold 3.8% of their holdings

    $118k5,700 shares at $20.70

    Filed Jan 10, 2020Form 4

  6. Dec 30, 2019Plan not stated

    FATE

    Sold 16.8% of their holdings

    $487k25,000 shares at $19.49

    Filed Jan 2, 2020Form 4

  7. Oct 15, 2019Plan not stated

    FATE

    Sold 8.7% of their holdings

    $169k11,800 shares at $14.29

    Filed Oct 16, 2019Form 4

  8. Jun 27, 2019Plan not stated

    FATE

    Sold 8.4% of their holdings

    $253k12,500 shares at $20.21

    Filed Jun 28, 2019Form 4

  9. Mar 28, 2019Plan not stated

    FATE

    Sold 8.4% of their holdings

    $212k12,500 shares at $16.94

    Filed Mar 29, 2019Form 4

  10. Oct 16, 2017Plan not stated

    FATE

    Sold 12.7% of their holdings

    $51k13,225 shares at $3.87

    Filed Oct 17, 2017Form 4

10 of 11

Every transaction

Every transaction on a Form 4 or Form 5 by Shoemaker Daniel D
TradedFiledStockRoleWhatAmountPriceValueHeld afterSource
Mar 8, 2021Mar 9, 2021FATEChief Scientific OfficerSold25,000$81.73$2M73,020SEC
Jan 20, 2021Jan 22, 2021FATEChief Scientific OfficerAwardedStock Option (right to buy)5,4815,481SEC
Jan 20, 2021Jan 22, 2021FATEChief Scientific OfficerAwarded14,41198,020SEC
Jan 11, 2021Jan 12, 2021FATEChief Scientific OfficerSold9,482$114.95$1.1M83,609SEC
Nov 16, 2020Nov 16, 2020FATEChief Scientific OfficerSold25,000$51.83$1.3M93,091SEC
Sep 14, 2020Sep 16, 2020FATEChief Scientific OfficerSold25,000$36.30$908k118,091SEC
Jan 8, 2020Jan 10, 2020FATEChief Scientific OfficerSold5,700$20.70$118k143,091SEC
Jan 8, 2020Jan 10, 2020FATEChief Scientific OfficerAwardedStock Option (right to buy)90,00090,000SEC
Jan 8, 2020Jan 10, 2020FATEChief Scientific OfficerAwarded25,000148,791SEC
Dec 30, 2019Jan 2, 2020FATEChief Scientific OfficerSold25,000$19.49$487k123,791SEC
Dec 30, 2019Jan 2, 2020FATEChief Scientific OfficerExercised or settledStock Option (right to buy)25,00098,800SEC
Dec 30, 2019Jan 2, 2020FATEChief Scientific OfficerExercised options25,000$2.90$73k148,791SEC
Oct 15, 2019Oct 16, 2019FATEChief Scientific OfficerSold11,800$14.29$169k123,791SEC
Jun 27, 2019Jun 28, 2019FATEChief Scientific OfficerSold12,500$20.21$253k135,591SEC
Jun 27, 2019Jun 28, 2019FATEChief Scientific OfficerExercised or settledStock Option (right to buy)12,500123,800SEC
Jun 27, 2019Jun 28, 2019FATEChief Scientific OfficerExercised options12,500$2.90$36k148,091SEC
Mar 28, 2019Mar 29, 2019FATEChief Scientific OfficerSold12,500$16.94$212k135,591SEC
Mar 28, 2019Mar 29, 2019FATEChief Scientific OfficerExercised or settledStock Option (right to buy)12,500136,300SEC
Mar 28, 2019Mar 29, 2019FATEChief Scientific OfficerExercised options12,500$2.90$36k148,091SEC
Jan 7, 2019Jan 9, 2019FATEChief Scientific OfficerAwardedStock Option (right to buy)135,000135,000SEC
Jan 7, 2019Jan 9, 2019FATEChief Scientific OfficerAwarded45,000135,591SEC
Jan 16, 2018Jan 17, 2018FATEChief Scientific OfficerAwardedStock Option (right to buy)186,000186,000SEC
Oct 16, 2017Oct 17, 2017FATEChief Scientific OfficerSold13,225$3.87$51k90,591SEC
Jan 4, 2017Jan 6, 2017FATEChief Scientific OfficerAwardedStock Option (right to buy)150,000150,000SEC
Jan 8, 2016Jan 12, 2016FATEChief Scientific OfficerAwardedStock Option (right to buy)148,800148,800SEC
Jan 8, 2016Jan 12, 2016FATEChief Scientific OfficerAwarded9,388103,816SEC
Oct 15, 2015Oct 16, 2015FATEChief Scientific OfficerAwarded66,00094,428SEC
Jan 5, 2015Jan 7, 2015FATEChief Research OfficerAwardedStock Option (right to buy)70,00070,000SEC
Jan 5, 2015Jan 7, 2015FATEChief Research OfficerAwarded2,46628,428SEC
Mar 31, 2014Apr 2, 2014FATEChief Technology OfficerSold8,653$9.86$85k25,962SEC
Jan 9, 2014Jan 10, 2014FATEChief Technology OfficerAwardedStock Option (right to buy)85,00085,000SEC

Sales and notices (11)

Form 144 notices and Form 4 sales by Shoemaker Daniel D
Source
Mar 8, 2021Mar 9, 2021FATEChief Scientific OfficerForm 4 sale25,000$2M25.5%UnusualSEC
Jan 11, 2021Jan 12, 2021FATEChief Scientific OfficerForm 4 sale9,482$1.1M10.2%Plan not statedSEC
Nov 16, 2020Nov 16, 2020FATEChief Scientific OfficerForm 4 sale25,000$1.3M21.2%Plan not statedSEC
Sep 14, 2020Sep 16, 2020FATEChief Scientific OfficerForm 4 sale25,000$908k17.5%Plan not statedSEC
Jan 8, 2020Jan 10, 2020FATEChief Scientific OfficerForm 4 sale5,700$118k3.8%Plan not statedSEC
Dec 30, 2019Jan 2, 2020FATEChief Scientific OfficerForm 4 sale25,000$487k16.8%Plan not statedSEC
Oct 15, 2019Oct 16, 2019FATEChief Scientific OfficerForm 4 sale11,800$169k8.7%Plan not statedSEC
Jun 27, 2019Jun 28, 2019FATEChief Scientific OfficerForm 4 sale12,500$253k8.4%Plan not statedSEC
Mar 28, 2019Mar 29, 2019FATEChief Scientific OfficerForm 4 sale12,500$212k8.4%Plan not statedSEC
Oct 16, 2017Oct 17, 2017FATEChief Scientific OfficerForm 4 sale13,225$51k12.7%Plan not statedSEC
Mar 31, 2014Apr 2, 2014FATEChief Technology OfficerForm 4 sale8,653$85k25.0%Plan not statedSEC